CervoMed Inc. Finite-Lived Intangible Assets, Amortization Expense, Next Rolling Twelve Months
CervoMed Inc. (CRVO) had Finite-Lived Intangible Assets, Amortization Expense, Next Rolling Twelve Months of $1.23 million as of 2014-09-30, per its 10-Q filed 2014-11-12.
Discontinued › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, after Accumulated Amortization, Rolling Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths · last filed 2014-11-12
- 2014-09-30: Finite-Lived Intangible Assets, Amortization Expense, Next Rolling Twelve Months $1.23M.
- 2014-06-30: Finite-Lived Intangible Assets, Amortization Expense, Next Rolling Twelve Months $1.28M.
| Period end | Finite-Lived Intangible Assets, Amortization Expense, Next Rolling Twelve Months |
|---|---|
| 2014-09-30 | $1.23M 10-Q · filed 2014-11-12 |
| 2014-06-30 | $1.28M 10-Q · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |